{
    "download_date": [
        "ClinicalTrials.gov processed this data on May 09, 2023"
    ],
    "link_text": [
        "Link to the current ClinicalTrials.gov record."
    ],
    "url": [
        "https://clinicaltrials.gov/show/NCT05389774"
    ],
    "org_study_id": [
        "21RM052"
    ],
    "nct_id": [
        "NCT05389774"
    ],
    "brief_title": [
        "DOLCE: Determining the Impact of Optellum's Lung Cancer Prediction Solution"
    ],
    "acronym": [
        "DOLCE"
    ],
    "official_title": [
        "DOLCE: Determining the Impact of Optellum's Lung Cancer Prediction (LCP) Artificial Intelligence Solution on Service Utilisation, Health Economics and Patient Outcomes"
    ],
    "lead_sponsor": [],
    "collaborator": [],
    "source": [
        "Nottingham University Hospitals NHS Trust"
    ],
    "has_dmc": [
        "No"
    ],
    "is_fda_regulated_drug": [
        "No"
    ],
    "is_fda_regulated_device": [
        "No"
    ],
    "textblock": [
        "This study is a multi-centre prospective observational cohort study recruiting patients with\r\n      5-30mm solid and part-solid pulmonary nodules that have been detected on CT chest scans\r\n      performed as part of routine practice. The aim is to determine whether physician decision\r\n      making with the AI-based LCP tool, generates clinical and health-economic benefits over the\r\n      current standard of care of these patients."
    ],
    "overall_status": [
        "Recruiting"
    ],
    "type": [
        "Actual",
        "Anticipated",
        "Anticipated",
        "Anticipated",
        "Actual",
        "Actual"
    ],
    "start_date": [
        "March 23, 2023"
    ],
    "completion_date": [
        "August 2024"
    ],
    "primary_completion_date": [
        "June 2024"
    ],
    "study_type": [
        "Observational"
    ],
    "has_expanded_access": [
        "No"
    ],
    "observational_model": [
        "Cohort"
    ],
    "time_perspective": [
        "Prospective"
    ],
    "measure": [
        "Determine the potential effect of the LCP on discharge",
        "Determine the potential effect of the LCP on overall clinical management, as well as scan and procedure utilization.",
        "Determine the potential effect of the hypothetical LCP-informed care versus standard care on patient outcomes.",
        "Determine the potential health-economic effect of the hypothetical LCP-informed care versus standard care"
    ],
    "time_frame": [
        "up to 1 year.",
        "up to 1 year.",
        "up to 1 year.",
        "up to 1 year."
    ],
    "description": [
        "Measured difference between standard care, LCP and LCP-guided care for:\r\nPercentage of cancer patients discharged (straight after assessment of the baseline scan)\r\nPercentage of benign-nodule patients discharged (straight after assessment of the baseline scan)",
        "Percentage of cancer patients for whom there would have been a change in clinical management by LCP and LCP-guided care compared with the actual (standard) care (correctly by more aggressive management and incorrectly for less aggressive management).\r\nPercentage of benign-nodule patients for whom there would have been a change in clinical management by LCP and LCP-guided care compared with the actual (standard) care (incorrectly by more aggressive management and correctly for less aggressive management).\r\nMeasured difference between standard care, LCP and LCP-guided care for:\r\nPercentage of CT scans and PET/CT scans performed on benign-nodule patients\r\nPercentage of non-surgical biopsies performed on benign-nodule patients\r\nPercentage of surgical excisions on benign-nodule patients",
        "Measured difference between standard care, LCP and LCP-guided care for:\r\nPercentage of thoracic, respiratory or vascular events related to biopsies or surgical excisions for lung nodules or suspected lung cancer occurring within 30 days of the procedure on benign-nodule patients\r\nPercentage of lung cancers stratified by stage\r\nTime in days between nodule detection and lung cancer diagnosis",
        "Measured difference between standard care, LCP and LCP-guided care for:\r\nThe composite standardized GBP costs of all healthcare-related activity for lung nodules or suspected lung cancer\r\nHealth-related utilities (life years and QALYs)"
    ],
    "enrollment": [
        2000.0
    ],
    "condition": [
        "AI (Artificial Intelligence)",
        "Pulmonary Nodule, Solitary",
        "Pulmonary Nodule, Multiple",
        "Lung Cancer"
    ],
    "study_pop": [],
    "sampling_method": [
        "Non-Probability Sample"
    ],
    "criteria": [],
    "gender": [
        "All"
    ],
    "minimum_age": [
        "35 Years"
    ],
    "maximum_age": [],
    "healthy_volunteers": [
        "No"
    ],
    "facility": [],
    "status": [
        "Not yet recruiting",
        "Recruiting",
        "Not yet recruiting",
        "Not yet recruiting",
        "Not yet recruiting",
        "Not yet recruiting",
        "Not yet recruiting",
        "Not yet recruiting",
        "Not yet recruiting",
        "Not yet recruiting"
    ],
    "contact": [],
    "investigator": [],
    "country": [
        "United Kingdom"
    ],
    "verification_date": [
        "March 2023"
    ],
    "study_first_submitted": [
        "May 16, 2022"
    ],
    "study_first_submitted_qc": [
        "May 20, 2022"
    ],
    "study_first_posted": [
        "May 25, 2022"
    ],
    "last_update_submitted": [
        "March 31, 2023"
    ],
    "last_update_submitted_qc": [
        "March 31, 2023"
    ],
    "last_update_posted": [
        "April 3, 2023"
    ],
    "responsible_party_type": [
        "Sponsor"
    ],
    "mesh_term": [
        "Solitary Pulmonary Nodule"
    ]
}